Valbiotis announces the holding of its Combined General Meeting of Shareholders on May 2, 2023 – 04/14/2023 at 5:40 p.m.


La Rochelle, April 14, 2023 (5:40 p.m. CEST) – Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible), a commercial-scale Research and Development company, committed to scientific innovation, for the prevention and fight against metabolic diseases and cardiovascular diseases, announces the holding of its Combined General Meeting of Shareholders on

May 2, 2023 and the procedures for making the preparatory documents available or consulting them.

The General Meeting of Shareholders will be held at:

The ENCAN space – Quai Louis Prunier – 17000 La Rochelle

May 2, 2023 at 9:30 a.m.

To attend the General Meeting, it is essential to be in possession of an admission card and an identity document.

The Management Board of Valbiotis invites the shareholders to vote on the resolutions, in particular, on resolutions n° 4 & 5 relating to the renewal of the independent members of the supervisory board Messrs. ZETLAOUI and LEVY and draws their attention to the publication of an additional report dated April 6, 2023, which supplements the content of the management report of the Management Board and the report of the Supervisory Board on corporate governance dated March 14, 2023, highlighting in particular the independent nature of the members of the Supervisory Board , within the meaning of the corporate governance code as amended in September 2021 by MiddleNext.



Source link -86